Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomarker Insights|November 3, 2025
Advancing Clinical Use of Neurofilament Light Chain: Translational Insights From Research to Routine PracticeEvelina La Civita, Valerio Nicolella, Mariano Fiorenza, et al.
Clinical Neurology and Neurosurgery|June 22, 2024
Tango classes in people with Multiple Sclerosis (PwMS): Impact on motor and non-motor functionsAssunta Trinchillo, Daniele Caliendo, Valerio Nicolella, et al.
International Journal of Molecular Sciences|June 10, 2023
Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable DiseaseValentina Rubino, Flavia Carriero, Anna Teresa Palatucci, et al.
Annals of Clinical and Translational Neurology|October 1, 2024
Dysphagia assessment in patients with multiple sclerosis - an additional piece to disability burdenDavide Ranucci, Fabrizia Falco, Valerio Nicolella, et al.
Multiple Sclerosis and Related Disorders|June 30, 2026
Real-world analytical and clinical evaluation of the Siemens Atellica® immunoassay for plasma neurofilament light chain in multiple sclerosisValerio Nicolella, Carmela Polito, Vincenzo Criscuolo, et al.
Multiple Sclerosis and Related Disorders|November 7, 2025
Anti-EBV antibody reduction during ocrelizumab treatment is not associated with multiple sclerosis outcomesAntonio Esposito, Luca Corsaro, Ilaria Delle Cave, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2025
Dysarthria assessment in multiple sclerosis patientsDavide Ranucci, Fabrizia Falco, Valerio Nicolella, et al.
Journal of the Neurological Sciences|June 7, 2025
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosisFederica Novarella, Valerio Nicolella, Mariano Fiorenza, et al.
Journal of Neurology|July 9, 2025
Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosisValerio Nicolella, Marco Varelli, Stefania Fasano, et al.
Pageof 2